Helius Medical Inc
11
0
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Portable Neuromodulation Stimulator (PoNS®) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.
Role: lead
PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study
Role: lead
Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis
Role: lead
A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)
Role: lead
PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI)
Role: lead
Efficacy of PoNS in Reducing Symptoms of Multiple Sclerosis
Role: lead
Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)
Role: lead
PoNS Clinical Experience Program (TBI)
Role: lead
PoNS Clinical Experience Program (TBI)
Role: lead
PoNS Clinical Experience Program (TBI)
Role: lead
PoNS Clinical Experience Program (TBI)
Role: lead
All 11 trials loaded